Medpace
MEDP
610.54
-23.44
-3.70%
Medpace
US · MEDP
#1015 by market cap
Listed 2016
610.54
-23.44
-3.70%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Mizuho Securities Maintains Medpace(MEDP.US) With Buy Rating, Raises Target Price to $700Market Newswire · 2026/10/7
-
Rating change
Baird Downgrades Medpace(MEDP.US) to Hold Rating, Raises Target Price to $547Market Newswire · 2026/7/8
-
Rating change
Mizuho Securities Maintains Medpace(MEDP.US) With Buy Rating, Maintains Target Price $665Market Newswire · 2026/7/29
-
Rating change
A Quick Look at Today's Ratings for Medpace(MEDP.US), With a Forecast Between $400 to $477Market Newswire · 2026/4/25
-
Rating change
UBS Maintains Medpace(MEDP.US) With Hold Rating, Maintains Target Price $673Market Newswire · 2026/10/3
-
Form 144 | Medpace(MEDP.US) Officer Proposes to Sell 10.87 Million in Common StocksMarket Newswire · 2026/10/27
-
A Quick Look at Today's Ratings for Medpace(MEDP.US), With a Forecast Between $675 to $730Market Newswire · 2026/10/23
-
Rating change
A Quick Look at Today's Ratings for Medpace(MEDP.US), With a Forecast Between $535 to $692Market Newswire · 2026/7/24
-
Rating change
Barclays Maintains Medpace(MEDP.US) With Hold Rating, Raises Target Price to $625Market Newswire · 2026/10/7
-
Rating change
Jefferies Maintains Medpace(MEDP.US) With Buy Rating, Cuts Target Price to $490Market Newswire · 2026/6/15
-
Rating change
UBS Initiates Medpace(MEDP.US) With Hold Rating, Announces Target Price $673Market Newswire · 2026/9/30
-
Rating change
Mizuho Securities Maintains Medpace(MEDP.US) With Buy Rating, Raises Target Price to $665Market Newswire · 2026/7/25
-
Rating change
Mizuho Securities Maintains Medpace(MEDP.US) With Buy Rating, Raises Target Price to $586Market Newswire · 2026/7/13
-
A Quick Look at Today's Ratings for Medpace(MEDP.US), With a Forecast Between $673 to $730Market Newswire · 2026/10/24
-
Rating change
William Blair Initiates Medpace(MEDP.US) With Hold RatingMarket Newswire · 2026/7/23
-
Medpace(MEDP.US) Officer Sells US$13.54 Million in Common StockMarket Newswire · 2026/10/29
-
Rating change
RBC Capital Maintains Medpace(MEDP.US) With Buy Rating, Maintains Target Price $692Market Newswire · 2026/10/7
-
Rating change
Truist Financial Maintains Medpace(MEDP.US) With Hold RatingMarket Newswire · 2026/9/17
-
BMO Capital Maintains Medpace(MEDP.US) With Hold Rating, Raises Target Price to $670Market Newswire · 2026/10/26
-
Rating change
Truist Financial Maintains Medpace(MEDP.US) With Hold Rating, Maintains Target Price $609Market Newswire · 2026/7/29
-
GUIDANCE: (MEDP) Medpace Expects Full Year 2026 Revenue Range $2.84B - $2.86B, Vs. FactSet Est of $2.85BMT Newswires · 2026/10/22
-
Earnings Flash (MEDP) Medpace Posts Q3 EPS $4.84, Vs. FactSet Est of $4.44MT Newswires · 2026/10/22
-
Rating change
William Blair Maintains Medpace(MEDP.US) With Hold RatingMarket Newswire · 2026/4/23
-
Rating change
RBC Capital Initiates Medpace(MEDP.US) With Buy Rating, Announces Target Price $522Market Newswire · 2026/3/3
-
Rating change
Jefferies Maintains Medpace(MEDP.US) With Buy Rating, Raises Target Price to $560Market Newswire · 2026/2/13
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Medpace discussion 0 comments